STERIS to sell Renal Care business to Evoqua Water Technologies for ~$196M cash

STERIS plc

Cash consideration of approximately $196 million, subject to customary working capital and other adjustments.
Transaction expected to close in Q1 2022, subject to regulatory review and customary closing conditions.
Proceeds to be used to pay down debt.
Renal Care business was acquired as part of the Cantel Medical transaction in June 2021.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.